Latest stories on NSPR
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference
StockTitan55 · neutralgeneral
InspireMD, Inc. Q2 2026 Earnings Call Summary
Yahoo Finance50 · neutralearnings
InspireMD signals potential FDA decisions in Q4 2026 while targeting $9M in annual cost savings
Seeking Alpha58 · neutralgeneral
InspireMD, Inc. (NSPR) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
InspireMD, Inc. (NSPR) files 8-K
SEC 8-K50 · neutralgeneral
InspireMD GAAP EPS of -$0.17, revenue of $1.77M misses by $0.36M
Seeking Alpha28 · bearishearnings
InspireMD Reports Second Quarter 2026 Financial Results
Business Insider50 · neutralearnings
InspireMD Reports Second Quarter 2026 Financial Results
GlobeNewswire50 · neutralearnings
Here are the major earnings before the open Monday
Seeking Alpha50 · neutralearnings
InspireMD Q2 2026 Earnings Preview
Seeking Alpha34 · bearishearnings
InspireMD to Announce Second Quarter 2026 Financial Results
StockTitan50 · neutralgeneral
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
InspireMD Eliminates Chief Commercial Officer Position
TipRanks34 · bearishgeneral
InspireMD, Inc. (NSPR) files 8-K
SEC 8-K50 · neutralgeneral
InspireMD Receives Nasdaq Notice on Bid Price Compliance
TipRanks34 · bearishgeneral
InspireMD, Inc. (NSPR) files 8-K
SEC 8-K34 · bearishgeneral
InspireMD, Inc. (NSPR) files 8-K
SEC 8-K50 · neutralgeneral
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NSPR Stock News
StockTitan50 · neutralgeneral
InspireMD, Inc. (NSPR) files 8-K
SEC 8-K50 · neutralgeneral